
A3K Pharmaceuticals Private Limited
Founded in 2014 and headquartered in Uttarakhand, India.
Founded in 2014 and headquartered in Uttarakhand, India.
Haridwar, Uttarakhand, India
+91-XXXXXXXXXX
U74999UR2014PTC001126
001126
Private Limited Indian Non-Government Company
20 May 2014
30 Sep 2017
31 Mar 2017
Unlisted
Roc-Uttarakhand
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhishek Kumar ![]() | Director | 20-May-2014 | Current |
Akshay Kumar ![]() | Director | 20-May-2014 | Current |
Anand Khaitan ![]() | Director | 20-May-2014 | Current |
A3K Pharmaceuticals Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 70% increase in profit. The company's net worth observed a substantial decline by a decrease of 30%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2016, A3K Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Anand Khaitan is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with A3K Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of A3K Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A3K Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A3K Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records.
A3K Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with RoC-Uttarakhand.
Abhishek Kumar was appointed as a Director was appointed as a Director on 20 May 2014 & has been associated with this company since 11 years 12 days .
Akshay Kumar was appointed as a Director was appointed as a Director on 20 May 2014 & has been associated with this company since 11 years 12 days .
Anand Khaitan was appointed as a Director was appointed as a Director on 20 May 2014 & has been associated with this company since 11 years 12 days .
A3K Pharmaceuticals Private Limited was registered on 20 May 2014 with RoC-Uttarakhand & aged 11 years 12 days as per MCA records.
A3K Pharmaceuticals Private Limited was incorporated on 20 May 2014.
The authorized share capital of A3K Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with A3K Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of A3K Pharmaceuticals Private Limited is R-56 A- Bhandari Colony Subhash Nagar, Roorkee Haridwar, Uttarakhand, India, 247667.
The corporate identification number (CIN) of A3K Pharmaceuticals Private Limited is U74999UR2014PTC001126 and the company number is 001126 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2016 indicates that The net worth of A3K Pharmaceuticals Private Limited has experienced an downturn of -30.00%.
The most recent Balance Sheet for A3K Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2017.
Search company & director profiles for free and gain access to critical business data.